| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-06 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0005 |